Array Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 86   

Articles published

ARRY 7.30 -0.31 (-4.07%)
price chart
Why Array Biopharma Inc's Shares Skyrocketed
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Array Announces Agreement To Acquire ENCORAFENIB (LGX818)  MarketWatch
Why Array BioPharma Inc. Shares Skyrocketed 51% in January
What: Shares of Array BioPharma (NASDAQ: ARRY ) , a biopharmaceutical company that's focused on developing novel drugs to fight cancer, skyrocketed by 51% in January, based on data from S&P Capital IQ, after announcing a pipeline acquisition from ...
Why Array Biopharma Inc. Stock Roared Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Why Array Biopharma (ARRY) Stock Surged Yesterday  Bidness ETC
Why Delta Air Lines, Hawaiian Electric Industries, and Array BioPharma are 3 ...  Investorplace.com
Related articles »  
3 Reasons to Watch Array Biopharma Inc.
It is no secret that the risks associated with pharmaceutical development are considerable. The cost to develop a novel drug often exceeds $1 billion.
Does This 50% Price Target Hike For Array BioPharma Inc. Make Sense?
What: Shares of Array BioPharma (NASDAQ: ARRY ) , a biopharmaceutical company focused on developing novel small molecule cancer drugs, surged just shy of 10% on Monday following a hefty price target hike from brokerage firm Stifel Nicolaus.
Array Biopharma Inc. (NASDAQ:ARRY) Is going to Buy Worldwide Rights  Inside Trade
Company News: Array Biopharma Inc (NASDAQ:ARRY)  Realist Investor
Update: Short Interest of Array BioPharma Inc. Drops by -5%
Array BioPharma Inc. (NASDAQ:ARRY), A reduction of 1,341,545 shares or 5% was observed in the short interest of Array BioPharma Inc. The interest on March 31,2015 came in at 25,728,072 shares and as per the average daily trading of 2,210,704 shares, ...
Tuesday's Morning Outlook: Endocyte, Inc. (ECYT), Array BioPharma, Inc ...  WallStreet Scope
Array Biopharma Inc. (NASDAQ:ARRY) Share Rose by almost 10%
Array Biopharma Inc. (NASDAQ:ARRY) was a big mover last session, as the company saw its shares rise by almost 10% on the day.
Cantor Fitzgerald Reiterates "$13.00" Price Target for Array ...  The Legacy
Zacks Rating Update On Array BioPharma Inc.
Array Biopharma Inc (NASDAQ:ARRY) has received a short term rating of hold from research analysts at Zacks with a rank of 3. The company has been rated an average of 1 by 7 Wall Street Analysts.
Biggest Movers in Healthcare Stocks Now � MNKD ARRY BABY ACHN
Array Biopharma Inc (ARRY): ARRY stock is up 1.9% today. Natus Medical Inc (BABY): BABY stock is up 1.9% today. Achillion Pharmaceuticals (ACHN): ACHN stock is up 1.8% today.
Array BioPharma to regain global rights to cancer therapy
Array BioPharma (NASDAQ:ARRY) +24% AH says it reached a deal with Novartis (NYSE:NVS) to regain global rights to its binimetinib cancer treatment as well as an upfront payment of $85M.